Eli Lilly (LLY) has been one of the most searched-for stocks on Zacks.com lately. So, you might want to look at some of the facts that could shape the stock's performance in the near term. Shares of ...

We believe there is minimal cause for concern with LLY stock, which makes it attractive but highly sensitive to adverse events as its current valuation is extremely ...

We recently published a list of 12 Best Quality Stocks to Invest in Now. In this article, we are going to take a look at ...

Eli Lilly (LLY) closed the latest trading day ... changes in estimates have a direct relationship with upcoming stock price performance. To take advantage of this, we've established the Zacks ...

It's hard to argue with the kinds of results Eli Lilly ( LLY 1.71%) has produced over the past five years. The company has been one of the best-performing pharmaceutical giants, with its shares ...

Eli Lilly (LLY) closed the most recent trading day at $912.76, moving -1.82% from the previous trading session.

LLY's R&D expenses ratio of 24.4% underscores its highly promising R&D efforts, explaining their robust top/ bottom-line performance and promising FY2025 guidance. With the stock now trading ...

Whales with a lot of money to spend have taken a noticeably bullish stance on Eli Lilly. Looking at options history for Eli ...

Back in December, I argued why I was ready to upgrade the stock of the embattled weight loss drugs leader Eli Lilly and Company ... Alpha's Disclosure: Past performance is no guarantee of future ...